170 participants
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-07
- Start Date:
- 2025-02-01
- Completion:
- 2028-12-31
Conditions
- Hereditary Angioedema (HAE)
Interventions
- DRUG
No Results Yet